Insulin degludec and Zoledronic acid
Determining the interaction of Insulin degludec and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin Degludec
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec-Zoledronic Acid (Bone Health)
- Insulin degludec-Zoledronic Acid (Zometa)
- Insulin degludec-Zoledronic Acid Injection
- Insulin degludec-Zoledronic Acid Injection Concentrate
- Insulin degludec-Zoledronic acid Intravenous
- Insulin degludec-Zoledronic Acid IV
- Zoledronic acid-Insulin Degludec (U-100) Prefilled Pens
- Zoledronic acid-Insulin Degludec (U-100) Vials
- Zoledronic acid-Insulin Degludec (U-200) Prefilled Pens
- Zoledronic acid-Insulin degludec and liraglutide
- Zoledronic acid-Insulin degludec and liraglutide Subcutaneous
- Zoledronic acid-Insulin degludec Subcutaneous